COVID-19 RNA Based Vaccines and the Risk of Prion Disease
J. Bart Classen, MD, Microbiology & Infectious Diseases | 18 January 2021 Development of new vaccine technology has been plagued with problems in the past. The current RNA based SARS-CoV-2 vaccines were approved in the US using an emergency order without extensive long term safety testing. In this paper the Pfizer COVID-19 vaccine was evaluated for the potential to induce prion-based disease in vaccine recipients. The RNA sequence of the vaccine as well as the spike protein target interactionRead More→